Highlighted with 82 tables and 92 figures, this 173-page report “Global Pharmacovigilance and Drug Safety Software Market 2022-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmacovigilance and drug safety software market and all its sub-segments through extensively detailed classifications.
Global pharmacovigilance and Drug Safety Software market will reach $432.3 million by 2031, growing by 7.3% annually over 2022-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions.
Also, The increasing awareness about the role of pharmacovigilance in healthcare has led to the growth of the market over the recent years in terms of applications across industry verticals. The report also covers an overview of various technologies used in pharma software market
This report provides a comprehensive analysis of the global pharma industry, related vendors and end user segments, together with detailed forecasts through 2031. The study intends to help stakeholders better understand the data, key trends, drivers and restraints that affect their businesses.
Request Research Sample with Latest Industry Insights (173+ Pages Report): https://altusmarketresearch.com/reports/sample/43102
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global pharmacovigilance and drug Safety Software Market in every aspect of the classification from perspectives of Functionality, Clinical Phase, Method, Delivery Mode, Indication, End User, and Region.
Based on Functionality, the global Pharmacovigilance and Drug Safety Software Market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software
Based on Clinical Phase, the global Pharmacovigilance and Drug Safety Software Market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV
By Method, the global Pharmacovigilance and Drug Safety Software Market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining
By Delivery Mode, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• On-premise Delivery
• On-demand Delivery
By Indication, the global Pharmacovigilance and Drug Safety Software Market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Oncology
• Respiratory Disorders
• Cardiology
• Neurology
• Immunology
• Pain Management
• Other Indications
By End Users, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Business Process Outsourcing Firms (BPOs)
• Other End Users
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of all regional markets by country and split of each national market by Functionality, Delivery Mode and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including Pharmacovigilance and Drug Safety Software Market leaders and important emerging players.
Selected Key Players:
Ab Cube
Accenture PLC
ArisGlobal LLC
Cognizant Technology Solutions Corporation
Ennov Solutions Inc.
Extedo GmbH
Honeywell International Inc. (Sparta Systems Inc.)
IQVIA Inc.
Max Application
Oracle Corporation
Sarjen Systems Pvt. Ltd.
United BioSource LLC
Veeva Systems Inc.
Wipro Limited
